MICROPLEX N/Nc

Problem  A municipal wastewater treatment facility in Arizona uses an activated sludge system with 4 oxidation ditches to treat approximately 9 million gallons per day. The system frequently experiences intermittent foaming and settling issues. The operator was looking for a solution to the foaming and settling issues that would also provide operational stability throughout the

Problem  A small town in New Mexico (pop. 1,300) had a municipal wastewater system with a flow rate of 50,000 gallons per day. The system included a series of three lagoons that tapered to a depth of 13 feet. Pond 1 had an average sludge depth of 1.9 feet, Pond 2 averaged 3.5 feet, and

Problem  The existing wastewater treatment system uses 600 kg/day of diammonium phosphate (DAP) to provide the needed phosphorus concentration to maintain a healthy microbial population to treat wastewater. These microorganisms break down the organic matter being discharged from the paper processing facility. Without the correct concentration of available phosphorus, the microorganisms are unable to grow

Problem  A small town in Utah (pop. 1,800) had a municipal wastewater system with a flow rate of 192,000 gallons per day. The system included a series of four lagoons that tapered to a depth of 6 feet, although at this time only Ponds 1 and 2 were being evaluated for treatment as they were

Problem  A municipal wastewater treatment facility in Idaho uses a small, activated sludge system to treat 35,000 gallons per day (gpd); waste activated sludge (WAS) is removed from the system approximately every 2 to 3 weeks. The system frequently experienced intermittent foaming and settling issues, as well as seasonal impact from grease relating to the

Summary  In this study, a one-year bioremediation plan was implemented for a municipal wastewater treatment facility with 2 primary lagoons that were at risk of upset and in which wastewater processing capacity was reduced due to an increased sludge layer. Specific changes in strata microbial life were tracked through ATP and DNA analysis at quarterly